Phio Pharmaceuticals Income Statement (2012-2021) | PHIO

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2012	Jun2012	Sep2012	Dec2012	Mar2013	Jun2013	Sep2013	Dec2013	Mar2014	Jun2014	Sep2014	Dec2014	Mar2015	Jun2015	Sep2015	Dec2015	Mar2016	Jun2016	Sep2016	Dec2016	Mar2017	Jun2017	Sep2017	Dec2017	Mar2018	Jun2018	Sep2018	Dec2018	Mar2019	Jun2019	Sep2019	Dec2019	Mar2020	Jun2020	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021
Revenue & Cost
Revenue			0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B				0.00B	0.00B						0.00B	0.00B	0.00B	0.00B		0.00B
Interest expenses
Interest Expenses			0.00B
Interest Income - Net	-0.00B	-0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B		0.00B
Operating Items
Research & Development			0.00B	0.06B	0.01B	0.00B	0.00B		0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
R&D In Process																					0.00B	0.00B
Selling, General & Administrative			0.00B	0.04B	0.00B	0.00B	0.00B		0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Restructuring Costs			0.00B	0.03B	0.00B
Other Operating Expenses			-0.00B	-0.12B	-0.00B			0.00B													0.00B	0.00B
Operating Expenses			0.00B	0.00B	0.01B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Operating Income			-0.00B	-0.10B	-0.01B	-0.00B	-0.00B		-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.01B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B
EBIT			-0.00B	-0.10B	-0.01B	-0.00B	-0.00B		-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.01B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B
Non-operating items
Interest & Investment Income						0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Other Non Operating Income			0.00B	0.01B	-0.00B		0.00B	0.01B	0.01B	0.00B	-0.00B			-0.00B			0.00B	-0.00B
Non Operating Income			0.00B	0.01B	-0.00B		0.00B	0.01B	0.01B	0.00B	0.00B		0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.00B					-0.00B		-0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B	-0.00B
Net income details
EBT			-0.00B	-0.09B	-0.01B	-0.00B	-0.00B		-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.01B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B
Tax Provisions																					-0.00B
Profit After Tax			-0.00B	-0.09B	-0.01B	-0.00B	-0.00B		-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.01B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B
Income from Continuing Operations			-0.00B	-0.09B	-0.01B	-0.00B	-0.00B		-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.01B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B
Consolidated Net Income			-0.00B	-0.09B	-0.01B	-0.00B	-0.00B		-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.01B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B
Income towards Parent Company			-0.00B	-0.09B	-0.01B	-0.00B	-0.00B		-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.01B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B
Preferred Dividend Payments			0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Net Income towards Common Stockholders			-0.00B	-0.10B	-0.02B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.01B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B
Additional items
EPS (Basic)			-0.56	-22.23	-2.76	-0.39	-0.30	-0.12	-0.32	-0.23	-0.17	-0.17	-1.32	-0.50	-0.38	-0.53	-3.41	-3.38	-3.36	-6.54	-2.65	-1.12	-1.05	-0.89	-0.90	-0.46	-0.34	-13.48	-5.71	-4.62	-4.53	-5.79	-1.33	-0.34	-0.40	-0.41
Shares Outstanding (Weighted Average)	47.97B	0.00B	0.01B	0.00B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.02B	0.02B	0.00B	0.00B	0.01B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.00B	0.01B	0.01B	0.01B
Shares Outstanding (Diluted Average)																																					0.01B	0.01B	0.01B
EBITDA			-0.00B	-0.10B	-0.01B	-0.00B	-0.00B		-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.01B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B
Tax Rate																					22.89%

Research Tools

Phio Pharmaceuticals Income Statement (2012-2021) | PHIO

Create an account

Sign In

Reset Password